It's about working with providers who understand metabolic health deeply enough to guide you toward what actually works for your situation
But much of this is anecdotal or case-report level, not from large randomized controlled trials
For this reason, it has been suggested that measured hypoglycaemia in patients after bariatric surgery is only relevant when associated with symptoms that are relieved by ingestion of carbohydrates (Whipples triad) 69
doi: 10.1001/jama.286.17.2136
GLP-1's roles in the body include: Stimulating insulin secretion from the pancreas in a glucose-dependent manner Suppressing glucagon (which otherwise drives the liver to release stored glucose) Slowing gastric emptying, which prolongs feelings of fullness Signaling satiety centers in the brain to reduce appetite Supporting healthy blood glucose levels already in the normal range GLP-1's challenge is that it has a very short half-life in the bloodstream (typically just 2 minutes) before an enzyme called DPP-4 breaks it down
demonstrated that consumers/patients tend to report suspected ADRs more frequently when these are serious ( The most reported suspected ADRs in suspected counterfeiting cases were vomiting, nausea, hypoglycemia, diarrhoea, malaise, dehydration, and pancreatitis
